Latest Orphan drugs Stories
Initiation of Registrational Studies Planned for This Year MORRISTOWN, N.J., Jan.
- Data Show Significant Survival Improvement with CPX-351 in Poor-Risk Patients - EWING, N.J., Jan. 12, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
New report from Kantar Health shows opportunities for biosimilars are high in oncology, low in rheumatoid arthritis in China. Shanghai, China (PRWEB) December
SAN DIEGO, Dec. 22, 2014 /PRNewswire/ -- MEI Pharma, Inc.
Expects to complete submission in the first half of 2015 DUBLIN, Dec.
SAN DIEGO, Dec.
DALLAS, December 9, 2014 /PRNewswire/ -- RnRMarketResearch.com adds "Gaucher's Disease - Pipeline Review, H2 2014" market research report of 74 pages with an overview of
APTO-253 In Vivo Data Demonstrate Single-Agent and Combination Activity in AML SAN FRANCISCO, CA, Dec. 9, 2014 /PRNewswire/ - Aptose Biosciences Inc.
Follow-up data from the Phase 2 PCYC-1104 trial presented at the American Society of Hematology Annual Meeting show sustained efficacy and safety over time SAN FRANCISCO and RARITAN, N.J.,
- Note: This press release corresponds to abstracts 4453 and 4471 SAN FRANCISCO, Dec.